RP1L1

RP1L1 is a photoreceptor-specific, doublecortin (DC) domain-containing protein that localizes to the axoneme of photoreceptor outer segments and connecting cilia, where it functions in outer segment morphogenesis and maintenance of photosensitivity (PMID:19657028). RP1L1 physically interacts with RP1, and combined haploinsufficiency of both genes synergistically disrupts outer segment morphology and reduces photoreceptor function, while complete loss of Rp1L1 in mice causes progressive photoreceptor degeneration (PMID:19657028, PMID:27029556). Dominant missense mutations in RP1L1, notably R45W, cause occult macular dystrophy (OMD); the R45W variant acts through a toxic gain-of-function mechanism that hyperactivates microtubule binding via enhanced cation-π contacts with α-tubulin, mislocalizes RP1L1 and RP1, compromises photoreceptor viability, and dysregulates PI3K/Akt signaling (PMID:20826268, PMID:41555797, PMID:40450528).

1. 2003 Medium

   Identification of RP1L1 as a retina-specific gene encoding DC domains established it as a candidate photoreceptor ciliary protein related to the known retinitis pigmentosa gene RP1.

   Evidence cDNA cloning, RT-PCR, in situ hybridization, Northern blot confirming retina-restricted expression and DC domain architecture

   PMID:12634863 PMID:12724644

   Open questions at the time

   • No direct demonstration that RP1L1 DC domains bind microtubules
   • Subcellular localization within photoreceptors unknown
   • No functional assay for RP1L1 activity
2. 2009 High

   Knockout and epistasis studies demonstrated that RP1L1 is required for outer segment integrity and acts synergistically with RP1, while co-immunoprecipitation established their direct physical interaction.

   Evidence Rp1L1−/− mice with ERG, single-rod recordings, double heterozygote genetic epistasis, co-IP in transfected cells and retinal pull-down, immunolocalization to outer segment axoneme

   PMID:19657028

   Open questions at the time

   • Molecular mechanism of RP1L1 function at the axoneme not defined
   • Whether RP1L1 directly binds microtubules (versus indirect association) not tested biochemically
   • Role in cone versus rod photoreceptors not distinguished
3. 2010 High

   Discovery that dominant RP1L1 missense mutations (R45W, W960R) cause occult macular dystrophy linked RP1L1 dysfunction to human cone-mediated disease.

   Evidence Linkage analysis and candidate sequencing in multiple OMD families; immunohistochemistry in primate retina confirming rod and cone expression

   PMID:20826268

   Open questions at the time

   • Pathogenic mechanism of R45W versus W960R not determined
   • Whether mutations cause loss-of-function or gain-of-function unknown
   • No patient-derived cellular model
4. 2016 Medium

   Combinatorial knockdown of rp1l1 and c2orf71 in zebrafish revealed a genetic interaction between these two loci, extending the RP1L1 epistasis network beyond RP1.

   Evidence Zebrafish morpholino knockdown with combinatorial suppression, retinal and cerebellar integrity assays

   PMID:27029556

   Open questions at the time

   • Physical basis of RP1L1–C2orf71 interaction not established
   • Morpholino artifacts not excluded by genetic mutant confirmation
   • Relevance to mammalian photoreceptor disease uncertain
5. 2025 Medium

   Patient-derived photoreceptor-like cells showed that R45W disrupts RP1L1 and RP1 intracellular localization and compromises cell viability, implicating PI3K/Akt pathway dysregulation in OMD pathogenesis.

   Evidence iPSC-derived induced photoreceptor-like cells from OMD patients, immunofluorescence, transcriptomics, cell viability assay

   PMID:40450528

   Open questions at the time

   • Causal relationship between PI3K/Akt changes and photoreceptor death not established
   • Single lab study awaiting independent replication
   • Whether mislocalization is cause or consequence of toxicity unclear
6. 2026 High

   The R45W pathogenic mechanism was resolved as a toxic gain-of-function: the mutation creates aberrant cation-π contacts with α-tubulin that hyperactivate microtubule binding, and low-concentration glycerol selectively reverses this defect.

   Evidence Live-cell MT association imaging, in vitro MT binding assay, molecular dynamics simulations, glycerol rescue experiments

   PMID:41555797

   Open questions at the time

   • Whether glycerol rescue translates to in vivo photoreceptor protection untested
   • Structural basis at atomic resolution (cryo-EM or crystal structure) not available
   • Mechanism of the W960R variant not addressed

• Key unresolved questions include whether RP1L1 has additional functions beyond microtubule binding at the axoneme, how it coordinates with RP1 mechanistically in disc morphogenesis, and whether therapeutic disruption of hyperactive MT binding can prevent OMD progression in vivo.
• No high-resolution structure of RP1L1 DC domains bound to tubulin
• In vivo rescue of R45W phenotype not demonstrated
• Role of RP1L1 in cone-specific versus rod-specific outer segment biology undefined